HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 49.25
Year range
zł 47.00 - zł 72.40
Market cap
1.14B PLN
Avg Volume
2.37K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
(PLN) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 25.43M | 38.83% |
Operating expense | 43.04M | 40.05% |
Net income | -19.40M | -10.24% |
Net profit margin | -76.30 | 20.59% |
Earnings per share | — | — |
EBITDA | -19.69M | -35.46% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
(PLN) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 245.59M | -19.09% |
Total assets | 404.84M | -9.87% |
Total liabilities | 209.52M | 74.02% |
Total equity | 195.31M | — |
Shares outstanding | 23.12M | — |
Price to book | 5.83 | — |
Return on assets | -13.90% | — |
Return on capital | -20.28% | — |
Cash Flow
Net change in cash
(PLN) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -19.40M | -10.24% |
Cash from operations | -43.24M | -29.96% |
Cash from investing | 76.97M | 777.71% |
Cash from financing | 33.90M | -85.97% |
Net change in cash | 71.78M | -63.92% |
Free cash flow | -23.38M | -110.73% |
About
Founded
2007
Website
Employees
270